Welcome to the Hayeems Lab!
Dr. Robin Hayeems is a Scientist in the Child Health Evaluative Sciences (CHES) research program at The Hospital For Sick Children and an Associate Professor in the Institute of Health Policy, Management and Evaluation (IHPME) at the University of Toronto.
Hayeems and her team use novel research strategies to understand the impact of new genomic screening and diagnostic tests on families, health care providers, health care systems and society in order to optimize how they are implemented and used in clinical care.
Jegathisawaran J, Tsiplova K, Hayeems R, Ungar WJ. Determining accurate costs for genomic sequencing technologies-a necessary prerequisite. Journal of Community Genetics, 2019.
Azzopardi PJ, Upshur REG, Luca S, Venkataramanan V, Potter BK, Chakraborty PK, Hayeems RZ. Health-care providers’ perspectives on uncertainty generated by variant forms of newborn screening targets. Genetics in Medicine, 2019.
Hayeems RZ, Luca S, Ungar WJ, Bhatt A, Chad L, Pullenayegum E, Meyn MS. The development of the Clinician-reported Genetic testing Utility Index (C-GUIDE): A novel strategy for measuring the clinical utility of genetic testing. Genetics in Medicine, 2019.
Hayeems RZ, Luca S, Pullenayegum E, Meyn MS, Ungar WJ. Genome Diagnostics: Novel Strategies for Measuring Value. Journal of Managed Care & Specialty Pharmacy 2019 25:10, 1096-1101